Intracellular Th (ITCI) had the highest return in December 2019 by a mid-cap US stock, returning 248.7%.
Intracellular Th (ITCI) had the highest return in December 2019 by a mid-cap US stock, returning 248.7%.
Mid-cap stocks are treated as having a market cap between $2B and $10B.